Two Sigma Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-88,706
| Closed | -$3.41M | – | 3376 |
|
|
2023
Q2 | $3.41M | Sell |
88,706
-65,559
| -42% | -$1.68M | 0.01% | 1110 |
|
|
2023
Q1 | $3.57M | Buy |
154,265
+15,637
| +11% | +$373K | 0.01% | 1067 |
|
|
2022
Q4 | $3.63M | Sell |
138,628
-82,317
| -37% | -$1.82M | 0.01% | 1016 |
|
|
2022
Q3 | $4.34M | Buy |
220,945
+2,662
| +1% | +$53.4K | 0.01% | 809 |
|
|
2022
Q2 | $3.82M | Buy |
218,283
+197,801
| +966% | +$3.1M | 0.01% | 889 |
|
|
2022
Q1 | $335K | Sell |
20,482
-191,110
| -90% | -$2.6M | ﹤0.01% | 2176 |
|
|
2021
Q4 | $3.45M | Sell |
211,592
-112,853
| -35% | -$1.61M | 0.01% | 1460 |
|
|
2021
Q3 | $4.14M | Buy |
324,445
+233,448
| +257% | +$3.07M | 0.01% | 1373 |
|
|
2021
Q2 | $1.28M | Buy |
90,997
+73,815
| +430% | +$1.18M | ﹤0.01% | 2261 |
|
|
2021
Q1 | $267K | Sell |
17,182
-49,948
| -74% | -$815K | ﹤0.01% | 3419 |
|
|
2020
Q4 | $1.06M | Buy |
67,130
+29,002
| +76% | +$438K | ﹤0.01% | 1954 |
|
|
2020
Q3 | $463K | Sell |
38,128
-18,155
| -32% | -$243K | ﹤0.01% | 2307 |
|
|
2020
Q2 | $650K | Buy |
56,283
+40,386
| +254% | +$557K | ﹤0.01% | 1821 |
|
|
2020
Q1 | $218K | Sell |
15,897
-91,424
| -85% | -$1.08M | ﹤0.01% | 2597 |
|
|
2019
Q4 | $633K | Buy |
107,321
+47,138
| +78% | +$256K | ﹤0.01% | 2600 |
|
|
2019
Q3 | $319K | Sell |
60,183
-939
| -2% | -$6.23K | ﹤0.01% | 2930 |
|
|
2019
Q2 | $471K | Sell |
61,122
-17,267
| -22% | -$263K | ﹤0.01% | 2540 |
|
|
2019
Q1 | $1.56M | Sell |
78,389
-10,797
| -12% | -$188K | 0.01% | 1562 |
|
|
2018
Q4 | $1.18M | Buy |
89,186
+82,466
| +1,227% | +$1.65M | ﹤0.01% | 1547 |
|
|
2018
Q3 | $247K | Buy |
+6,720
| New | +$216K | ﹤0.01% | 2884 |
|
|
2018
Q1 | – | Sell |
-15,798
| Closed | -$592K | – | 3619 |
|
|
2017
Q4 | $592K | Buy |
+15,798
| New | +$690K | ﹤0.01% | 2316 |
|
|
2016
Q1 | – | Sell |
-4,142
| Closed | -$583K | – | 3204 |
|
|
2015
Q4 | $583K | Buy |
+4,142
| New | +$563K | ﹤0.01% | 1874 |
|
Two Sigma Investments's KDNY Position: Q3 2023 in Review
Two Sigma Investments sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 88,706 shares — an estimated $3.41M sold.
Two Sigma Investments first reported a position in KDNY in Q4 2015 and held it in 22 quarters. The position peaked at $4.34M in Q3 2022. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Two Sigma Investments reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Two Sigma Investments sold 88,706 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.41M.
- Two Sigma Investments first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2015 and held it in 22 quarters.
- Two Sigma Investments's Chinook Therapeutics, Inc. Common Stock position peaked at $4.34M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.